Bharat Biotech's Covid-19 vaccine named Covaxin will be available in the first quarter of 2021, said Suchitra Ella who is joint managing director of Bharat Biotech.
Ms Ella said, "With safety and efficacy data, Covaxin will be available in the first quarter of next year to the categories and the first responders according to the plan that government of India is embarking upon for phased vaccination."
Seeking emergency use authorization for Covid-19 vaccines, including Bharat Biotech, the United States based Pfizer and Pune-based Serum Institute of India (SII), have applied to Drugs Controller General of India (DGCI).
The Subject Expert Committee of Drugs Controller General of India has called for more safety and efficacy data of Covid-19 vaccines from Serum Institute of India and Bharat Biotech.
Meanwhile, a delegation of foreign heads of missions in India had visited leading biotech companies in Hyderabad who are involved in the development of Covid-19 vaccine.
